AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Watpride M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Watran Pharmaceuticals Pvt. Ltd.

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Watpride M 1mg/500mg Tablet SR

Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts, liver function) are recommended.

Primary Ingredients of Watpride M 1mg/500mg Tablet SR

No information provided. Please provide the text you wish to be rephrased.

Uses of Watpride M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Watpride M 1mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Watpride M 1mg/500mg Extended-Release tablets with food.

Common Side effects of Watpride M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Watpride M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Watpride M 1mg/500mg Extended-Release Tablet with a meal.

How Watpride M 1mg/500mg Tablet SR works:

Watpride M, a sustained-release tablet containing 1mg glimepiride and 500mg metformin, combines two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Watpride M 1mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Watpride M 1mg/500mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

The sustained-release combination tablet, Watpride M 1mg/500mg, is contraindicated during lactation. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Individuals with kidney impairment should use Watpride M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Watpride M 1mg/500mg SR tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Watpride M 1mg/500mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician. For patients exhibiting mild to moderate liver disease, initiate treatment with a reduced Watpride M 1mg/500mg Tablet SR dosage; its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Watpride M 1mg/500mg Tablet SR :

Should you forget to take a Watpride M 1mg/500mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Watpride M 1mg/500mg Tablet SR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Watpride M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Watpride M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Watpride M and seek immediate medical attention.
Watpride M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Watpride M 1mg/500mg Tablet SR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can result in vitamin B12 deficiency.
Prolonged use of Watpride M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with vitamin B12 is recommended by some researchers.
Watpride M 1mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Watpride M 1mg/500mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Watpride M 1mg/500mg Tabl...
45
MRP 52
13% off